Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

NCT01509053 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole (Abilify®) IM Depot Injection
DRUG: Oral aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.